Designing the future in pharmaceuticals, both generic and innovative
generic dosage forms means anticipating tomorrow's R&D needs while
building on today's technological strengths.
Developing tomorrow's pharmaceuticals requires a flexible and innovative
global organization that focuses on generic specialties and establishes
effective partnerships through IAGIM - an non profit Drug Development
Association specially catering for the 'Partnership Program' and IAGIM
The specialized Beverage, Food and Wine division is located at LocumEuro.
Cutting Edge Research and advanced technology is conducted into container-closure
systems, internal fluoride treatment of glassware, food, wine and champagne
microbiology, QC, processing and manufacture.
Successful partner commercialization requires
comprehensive drug development programs, advanced capabilities in design
formulation, process development, analytical, optimization, scale-up,
qualification, process validation, stability, and turnkey manufacturing
At Locum International these essential and critical parameters are firmly
in place allowing us to be successful today and well prepared for tomorrow.
Locum's advanced Generic Ready-to-Go CMC
Know-how databases are tried and tested in both the US and EU commercial
market place. LIG's CMC know-how is coupled with its state-of the-art
scientific and technical publishing division working in association
with IAGIM a unique Drug Development Association designed for both generic
and innovative firms.
The IAGIM-Bird bilateral Research Foundation
supports a global pharmaceutical sciences workshop
program in some 23 cities and countries in the US, EU and Pacific Rim
These technological interfaces are fully dovetailed and interwoven towards
LIG's global client base
in over 124 countries.
Today - Locum International Group is an modern high-tech and unique
organization that is clearly focussed on tomorrow's future generic drug